We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

138 hedge funds and large institutions have $334M invested in Rigel Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $265M → $334M (+$68.7M)

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more funds holding

Funds holding: 135 → 138 (+3)

0.32% less ownership

Funds ownership: 8.6% → 8.27% (-0.32%)

28% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 50

42% less call options, than puts

Call options by funds: $980K | Put options by funds: $1.69M

Holders
138
Holders Change
+3
Holders Change %
+2.22%
% of All Funds
2.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
36
Reduced
50
Closed
19
Calls
$980K
Puts
$1.69M
Net Calls
-$712K
Net Calls Change
-$707K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$16.1M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.11M
3
Morgan Stanley
Morgan Stanley
New York
+$3.76M
4
SGA
Sector Gamma AS
Norway
+$3.35M
5
RG
Redmile Group
California
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$5.98M
2
NMC
NEA Management Company
Maryland
-$5.93M
3
PAI
Palo Alto Investors
California
-$5.79M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.67M
5
CS
Candriam SCA
Luxembourg
-$4.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
RE
126
RBC Europe
United Kingdom
$3.6K – – –
Rockefeller Capital Management
127
Rockefeller Capital Management
New York
$3K – – –
PCM
128
Penserra Capital Management
California
$3K +$3.54K +144 New
Royal Bank of Canada
129
Royal Bank of Canada
Ontario, Canada
$2K -$29.5K -1,200 -93%
Bessemer Group
130
Bessemer Group
New Jersey
$2K – – –
Daiwa Securities Group
131
Daiwa Securities Group
Japan
$2K – – –
IA
132
IFP Advisors
Florida
$2K – – –
PGAM
133
Princeton Global Asset Management
New Jersey
$2K – – –
CG
134
Cutler Group
California
$2K +$2.95K +120 New
Millennium Management
135
Millennium Management
New York
$1.52K +$171K +6,955 +12%
ASN
136
Advisory Services Network
Georgia
$1K +$810 +33 New
NMC
137
NEA Management Company
Maryland
– -$5.93M -324,315 Closed
Two Sigma Investments
138
Two Sigma Investments
New York
– -$1.42M -77,453 Closed
Canada Pension Plan Investment Board
139
Canada Pension Plan Investment Board
Ontario, Canada
– -$1.22M -66,900 Closed
AC
140
Armistice Capital
New York
– -$957K -52,270 Closed
SI
141
Sofinnova Investments
California
– -$622K -33,970 Closed
WVP
142
Worth Venture Partners
New Jersey
– -$391K -21,404 Closed
DCM
143
DAFNA Capital Management
California
– -$289K -15,770 Closed
AIMCA
144
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$221K -12,060 Closed
GCP
145
GSA Capital Partners
United Kingdom
– -$155K -8,443 Closed
DTL
146
Dynamic Technology Lab
Singapore
– -$142K -7,739 Closed
TSS
147
Two Sigma Securities
New York
– -$68K -3,721 Closed
UBS Group
148
UBS Group
Switzerland
– -$64K -3,486 Closed
Walleye Capital
149
Walleye Capital
New York
– -$53K -2,900 Closed
Marshall Wace
150
Marshall Wace
United Kingdom
– -$50K -2,730 Closed
3 4 5
6
7

RIGL Hedge Fund Activity: Q3 2020 in Review

138 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2020, worth a combined $334M — up 26% from $265M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RIGL positions and 19 closed out — a net gain of 3 holders — while 36 added to existing stakes and 50 trimmed.

The largest buyer was State Street, adding an estimated $16.1M. The largest seller was Renaissance Technologies, cutting an estimated $5.98M.

  • 138 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2020, up from 135 in Q2 2020.
  • Funds reported $334M of Rigel Pharmaceuticals stock for Q3 2020, up 26% quarter-over-quarter.
  • 22 funds opened new Rigel Pharmaceuticals positions in Q3 2020 and 19 closed out, a net change of +3 holders.
  • The largest Rigel Pharmaceuticals buyer in Q3 2020 was State Street, an estimated $16.1M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2020 was Renaissance Technologies, an estimated $5.98M sold.

Based on aggregated 13F filings for Q3 2020.